Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status:
Terminated
Trial end date:
2012-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, efficacy, and
pharmacokinetics of milnacipran in pediatric patients aged 13 to 17 years with primary
fibromyalgia.